The innate capacity of human T cells to respond to Mycobacterium tuberculosis
The innate capacity of human T cells to respond to Mycobacterium tuberculosis
批准号:
8695288
负责人:
Deborah A. Lewinsohn
金额:
$39.6万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-07-05 至 2017-06-30
关键词:
Activities of Daily LivingAddressAdultAgeAnimal ModelAntigen-Presenting CellsAntigensBacillus (bacterium)Biological AssayBirthCD4 Positive T LymphocytesCD8B1 geneCell CommunicationCell MaturationCell physiologyCellsCharacteristicsClinical ResearchContainmentDendritic CellsDevelopmentDiseaseFlow CytometryFrequenciesGene ExpressionGene Expression ProfileGene Expression ProfilingGenetic PolymorphismGrowthHumanImmuneImmune responseImmune systemImmunityIndividualInfantInfection ControlInflammation MediatorsInflammatoryInterferon Type IIInterferonsInterleukin-12LigandsMass Spectrum AnalysisMediatingModelingMolecular ProfilingMononuclearMorbidity - disease rateMycobacterium tuberculosisNatural ImmunityNewborn InfantPathway interactionsPeripheral Blood Mononuclear CellPhenotypePopulationProductionRegulatory T-LymphocyteResearchSignal TransductionSourceStagingT cell responseT-Cell ReceptorT-LymphocyteT-Lymphocyte SubsetsTherapeuticToll-like receptorsTuberculosisTuberculosis VaccinesUmbilical Cord BloodVaccinationantimicrobialbasecell mediated immune responsecytokinedisease phenotypehuman morbidityhuman mortalityimprovedinfancymacrophagemicrobialmortalityneonatenext generationnovelnovel vaccinespathogenpreventpublic health relevancereactivation from latencyreceptorresponsevaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The human immune response to Mycobacterium tuberculosis (Mtb) permits establishment of latency and in some individuals, subsequent reactivation and disease. The host-pathogen interactions that prevent sterilizing immunity are not well understood. Emerging research demonstrates that among Mtb-na¿ve hosts, Mtb-reactive innate T cells with effector functions associated with protective immunity are present. Moreover, human na¿ve T cells are capable of using Toll-like receptors (TLR), molecules typically associated with innate immunity, to directly receive co-stimulatory signals from Mtb ligands. We hypothesize that Mtb-reactive innate T cells, and na¿ve T cells with functional innate co-stimulatory receptors, are a source of pro-inflammatory mediators such as IFN-? during the initial stages of Mtb infection. This early production of IFN-? and other effector molecules may augment antimicrobial responses by Mtb-infected macrophages, as well as IL-12 production by Mtb- infected dendritic cells. Defining and characterizing the repertoire of Mtb-reactive innate T cells, and na¿ve T cells with functional TLR, is an essential first step in the development of vaccines and immune-based therapeutics that expand these cells in order to bolster sterilizing immune responses against Mtb. The objectives of this proposal are to characterize the phenotype, frequency, effector potential, and gene expression profile of Mtb-reactive, innate T cells, as well as na¿ve T cell subsets (including regulatory T cells), that utilize TLR to respond o Mtb ligands, among Mtb-na¿ve hosts from birth to adulthood. The specific aims of this proposal are focused on investigating innate T cell responses to Mtb among antigen-inexperienced neonates and Mtb-naive infants and adults. We will use a novel assay to identify and quantify non-classically restricted Mtb-reactive T cells among donors of different ages, and a combination of flow cytometry, multiplex cytokine arrays, inorganic mass spectrometry, and gene expression profiling to delineate their phenotypes, functional capabilities, and molecular profiles. We will characterize the phenotype, functional capabilities, gene expression profiles, and T cell receptor diversity of na¿ve T cell subsets responsive to TLR-mediated co-stimulation among neonates, infants, and adults. We will also determine if age impacts TLR-mediated alterations of the suppressive functions of regulatory T cells. Our approach will allow us to determine if TLR-responsive na¿ve T cells isolated from antigen-inexperienced hosts, such as newborns, represent a unique subset of innate T cells. Understanding the ontogeny of innate T cells and the capacity of T cells to utilize innate receptors to alter their activation and functio, will advance our understanding of the full potential of T cell developmental pathways, as well as their contribution to host immune defense. In addition, as neonates and infants are exquisitely vulnerable to severe disease phenotypes from infectious pathogens, defining the innate capacity of their T cells to respond to a pathogen such as Mtb, can be used to inform the development of next generation vaccines and therapeutics utilized in infancy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The innate capacity of human T cells to respond to Mycobacterium tuberculosis
-
批准号:9096002
-
项目类别:
-
资助金额:$38.48万
-
财政年份:2013
-
负责人:Deborah A. Lewinsohn
-
依托单位:
The innate capacity of human T cells to respond to Mycobacterium tuberculosis
-
批准号:8583230
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2013
-
负责人:Deborah A. Lewinsohn
-
依托单位:
A CD8+ T cell diagnostic to identify children with pulmonary tuberculosis
-
批准号:8455954
-
项目类别:
-
资助金额:$97.69万
-
财政年份:2011
-
负责人:Deborah A. Lewinsohn
-
依托单位:
A CD8+ T cell diagnostic to identify children with pulmonary tuberculosis
-
批准号:8601417
-
项目类别:
-
资助金额:$99.68万
-
财政年份:2011
-
负责人:Deborah A. Lewinsohn
-
依托单位:
A CD8+ T cell Diagnostic to Identify Children with Pulmonary Tuberculosis
-
批准号:8122915
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2011
-
负责人:Deborah A. Lewinsohn
-
依托单位:
A CD8+ T cell Diagnostic to Identify Children with Pulmonary Tuberculosis
-
批准号:8233301
-
项目类别:
-
资助金额:$15.72万
-
财政年份:2011
-
负责人:Deborah A. Lewinsohn
-
依托单位:
INFANT RHESUS MACAQUE MODEL FOR SIV VACCINES
-
批准号:7348888
-
项目类别:
-
资助金额:$13.12万
-
财政年份:2006
-
负责人:Deborah A. Lewinsohn
-
依托单位:
AGE-RELATED CHANGES IN PRIMATE DENDRITIC CELL FUNCTION
-
批准号:6783961
-
项目类别:
-
资助金额:$16.96万
-
财政年份:2004
-
负责人:Deborah A. Lewinsohn
-
依托单位:
INFANT RHESUS MACAQUE MODEL FOR SIV VACCINES
-
批准号:6970636
-
项目类别:
-
资助金额:$10.53万
-
财政年份:2004
-
负责人:Deborah A. Lewinsohn
-
依托单位:
Tuberculosis Immunity in Young Children
-
批准号:6966206
-
项目类别:
-
资助金额:$7.31万
-
财政年份:2003
-
负责人:Deborah A. Lewinsohn
-
依托单位:
Tuberculosis Immunity in Young Children
-
批准号:6747926
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2003
-
负责人:Deborah A. Lewinsohn
-
依托单位:
Tuberculosis Immunity in Young Children
-
批准号:7074695
-
项目类别:
-
资助金额:$40.54万
-
财政年份:2003
-
负责人:Deborah A. Lewinsohn
-
依托单位:
Tuberculosis Immunity in Young Children
-
批准号:6596930
-
项目类别:
-
资助金额:$26.43万
-
财政年份:2003
-
负责人:Deborah A. Lewinsohn
-
依托单位:
Tuberculosis Immunity in Young Children
-
批准号:6883951
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2003
-
负责人:Deborah A. Lewinsohn
-
依托单位:
EVALUATION OF ADOPTIVE T CELL THERAPY FOR HIV
-
批准号:6168761
-
项目类别:
-
资助金额:$12.53万
-
财政年份:1998
-
负责人:Deborah A. Lewinsohn
-
依托单位:
EVALUATION OF ADOPTIVE T CELL THERAPY FOR HIV
-
批准号:2886131
-
项目类别:
-
资助金额:$8.37万
-
财政年份:1998
-
负责人:Deborah A. Lewinsohn
-
依托单位:
EVALUATION OF ADOPTIVE T CELL THERAPY FOR HIV
-
批准号:2874201
-
项目类别:
-
资助金额:$8.37万
-
财政年份:1998
-
负责人:Deborah A. Lewinsohn
-
依托单位:
EVALUATION OF ADOPTIVE T CELL THERAPY FOR HIV
-
批准号:6372642
-
项目类别:
-
资助金额:$12.53万
-
财政年份:1998
-
负责人:Deborah A. Lewinsohn
-
依托单位:
EVALUATION OF ADOPTIVE T CELL THERAPY FOR HIV
-
批准号:6532608
-
项目类别:
-
资助金额:$12.53万
-
财政年份:1998
-
负责人:Deborah A. Lewinsohn
-
依托单位:
AGE-RELATED CHANGES IN PRIMATE DENDRITIC CELL FUNCTION
-
批准号:7675408
-
项目类别:
-
资助金额:$25.36万
-
财政年份:--
-
负责人:Deborah A. Lewinsohn
-
依托单位:
海外基金